The genetic transformation of bone biology

Genes and Development

Volumn 13, Issue 23, 1999, Pages 3037-3051

  Karsenty, Gerard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CALCITRIOL; CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; LIGAND; OSTEOCALCIN; PARATHYROID HORMONE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ALBERS SCHOENBERG DISEASE; BONE DEVELOPMENT; BONE DISEASE; BONE GROWTH; BONE MINERALIZATION; BONE REMODELING; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; GENE CONTROL; GENETIC TRANSFORMATION; HORMONAL REGULATION; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; OSTEOSCLEROSIS; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CALCITONIN; CALCITRIOL; CELL DIFFERENTIATION; CYTOKINES; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HEDGEHOG PROTEINS; HUMANS; MAMMALS; MICE; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPETROSIS; OSTEOPOROSIS; OSTEOSCLEROSIS; PARATHYROID HORMONE; PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033402201     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.23.3037     Document Type: Review

References (151)

1. Amling, M., M. Priemel, T. Holzmann, K. Chapin, M. Rueger, R. Baron, and M.B. Demay. 1999. Rescue of the skeletal phenotype of vitamin D receptor ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology (in Press).
2. Anderson, D.M., E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, E.R. Roux, M.C. Teepe, R.F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature 390: 175-179.
3. Aubin, J.E. and F. Liu. 1996. The osteoblast lineage. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan), pp. 51-68. Academic Press, San Diego, CA.
4. Balsan, S., M. Garabedian, M. Larchet, A.M. Gorski, G. Cournot, C. Tau, A. Bourdeau, C. Silve, and C. Ricour. 1986. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J. Clin. Invest. 77: 1661-1667.
5. Banerjee, C., L.R. McCabe, J.Y. Choi, S.W. Hiebert, J.L. Stein, G.S. Stein, and J.B. Lian. 1997. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem. 66: 1-8.
6. Bitgood, M.J. and A.P. McMahon. 1995. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172: 126-138.
7. Bodine, P.V., R.A. Henderson, J. Green, M. Aronow, T. Owen, G.S. Stein, J.B. Lian, and B.S. Komm. 1998. Estrogen receptor-alpha is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 139: 2048-2057.
8. Bonadio, J., T.L. Suanders, E. Tsai, S.A. Goldstein, J. Morris-Wiman, L. Brinkley, D.F. Dolan, R.A. Altschuler, J.E. Hawkins, Jr., and J.F. Batemen. 1990. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc. Natl. Acad. Sci. 87: 7145-7149.
9. Bonewald, L.F. 1996. Transforming growth factor-β. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan), pp. 647-659. Academic Press, San Diego, CA.
10. Boskey, A.L., S. Gadaleta, C. Gundberg, S.B. Doty, P. Ducy, and G. Karsenty. 1998. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23: 187-196.
11. Boyce, B.F., T. Yoneda, C. Lowe, P. Soriano, and G.R. Mundy. 1992. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb hone in mice. J. Clin. Invest. 90: 1622-1627.
12. Brugge, J., P. Cotton, A. Lustig, W. Yonemoto, L. Lipsich, P. Coussens, J.N. Barrett, D. Nonner, and R.W. Keane. 1987. Characterization of the altered form of the c-src gene product in neuronal cells. Genes & Dev. 1: 287-296.
13. Bucay, N., I. Sarosi, C.R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H.L. Tan, W. Xu, D.L. Lacey, W.J. Boyle, and W.S. Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Dev. 12: 1260-1268.
14. Burgess, T.L., Y. Qian, S. Kaufman, B.D. Ring, G. Van, C. Capparelli, M. Kelley, H. Hsu, W.J. Boyle, C.R. Dunstan, S. Hu, and D.L. Lacey. 1999. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell. Biol. 145: 527-538.
15. Byers, P.H. and R.D. Steiner. 1992. Osteogenesis imperfecta. Annu. Rev. Med. 43: 269-282.
16. Canalis, E. 1993. Insulinlike growth factors and the local regulation of bone formation. Bone 14: 273-276.
17. Canalis, E. and L. Raisz. 1980. Effect of fibroblast growth factors on cultured fetal rat calvaria. Metabolism 29: 108-114.
18. Caswell, A.M., R.G.G. Russell, and M.P. Whyte. 1989. Hypophosphatasia: Pediatric forms. J. Pediatr. Endocrinol. 3: 73-92.
19. Chisaka, O. and M.R. Capecchi. 1991. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5. Nature 350: 473-479.
20. Chorev, M. and M. Rosenblatt. 1996. Parathyroid hormone: Structure-function relations and analog design. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan), pp. 305-323. Academic Press, san Diego, CA.
21. Chu, M.L., C.J. Williams, G. Pepe, J.L. Hirsch, D.J. Prockop, and F. Ramirez. 1983. Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature 304: 78-80.
22. Chuang, P.T. and A.P. McMahon. 1999. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 397: 617-621.
23. Cornish, J., K.E. Callon, A.R. King, G.J. Cooper, and I.R. Reid. 1998. Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am. J. Physiol. 275: E694-699.
24. Corral, D.A., M. Amling, M. Priemel, E. Loyer, S. Fuchs, P. Ducy, R. Baron, and G. Karsenty. 1998. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc. Natl. Acad. Sci. 95: 13835-13840.
25. Daculsi, G., P. Pilet, M. Cottrel, and G. Guicheux. 1999. Role of fibronectin during biological apatite crystal nucleation: ultrastructural characterization. J. Biomed. Mater. Res. 47: 228-233.
26. Darnay, B.G., J. Ni, P.A. Moore, and B.B. Aggarwal. 1999. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase. Identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274: 7724-7731.
27. Dodig, M., M.S. Kronenberg, A. Bedalov, B.E. Kream, G. Gronowicz, S.H. Clark, K. Mack, Y.H. Liu, R. Maxon, Z.Z. Pan, W.B. Upholt, and D.W. Rowe. 1996. Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J. Biol. Chem. 271: 16422-17429.
28. Dougall, W.C., M. Glaccum, K. Charrier, K. Rohrbach, K. Brasel, T. De Smedt, E. Daro, J. Smith, M.E. Tometsko, C.R. Maliszewski et al. 1999. RANK is essential for osteoclast and lymph node development. Genes & Dev. 13: 2412-2424.
29. Duong, L.T., P.T. Lakkakorpi, I. Nakamura, M. Machwate, R.M. Nagy, and G.A. Rodan. 1998. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of α(v)β3 integrin, and phosphorylated by src kinase. J. Clin. Invest. 102: 881-892.
30. Ducy, P. and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15: 1858-1869.
31. Ducy, P., C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, A. Bradley, and G. Karsenty. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382: 448-452.
32. Ducy, P., R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
33. Ducy, P., M. Starbuck, M. Priemel, J. Shen, G. Pinero, V. Geoffroy, M. Amling, and G. Karsenty. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes & Dev. 13: 1025-1036.
34. Dusso, A.S. and A.J. Brown. 1998. Mechanism of vitamin D action and its regulation. Am. J. Kidney Dis. 32: S13-24.
35. Erlebacher, A. and R. Derynck. 1996. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J. Cell. Biol. 132: 195-210.
36. Erlebacher, A., E.H. Filvaroff, S.E. Gitelman, and R. Derynck. 1995. Toward a molecular understanding of skeletal development. Cell 80: 371-378.
37. Erlebacher, A., E.H. Filvaroff, J.Q. Ye, and R. Derynck. 1998. Osteoblastic responses to TGF-beta during bone remodeling. Mol. Biol. Cell 9: 1903-1918.
38. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E.W. Shores, K.D. Brown, A. Leonardi, T. Tran, B.F. Boyce, and U. Siebenlist. 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes & Dev. 11: 3482-3496.
39. Frost, H.M. 1969. Tetracycline-based histological analysis of bone remodeling. Calcif. Tissue Res. 3: 211-237.
40. Gelb, B.D., G.P. Shi, H.A. Chapman, and R.J. Desnick. 1996. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273: 1236-1238.
41. Gerber, H.P., T.H. Vu, T.H. Ryan, A.M. Kowalski, Z. Werb, and N. Ferrara. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.Nat. Med.5: 623-629.
42. Gergen, J.P. and E. Wieschaus. 1986. Dosage requirements for runt in the segmentation of Drosophila embryos. Cell 45: 289-299.
43. Gerondakis, S., R. Grumont, I. Rourke, and M. Grossmann. 1998. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10: 353-359.
44. Glimcher, M.J. 1989. Mechanism of clacification: Role of collagen ribrils and collagen-phosphoprotein complexes in vitro and in vivo. Anatomical Rec. 224: 139-153.
45. Glimcher, M.J., A.J. Hodge, and F.O. Schmitt. 1957. Macromolecular aggregation states in relatin to mineralization: the collagen-hydroxyapatite system as studied in vitro. Proc. Natl. Acad. Sci. 43: 860-866.
46. Golden, A., S.P. Nemeth, and J.S. Brugge. 1986. Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity. Proc. Natl. Acad. Sci. 83: 852-856.
47. Goodman, W.G., J.A. Ramirez, T.R. Belin, Y. Chon, B. Gales, G.V. Segre, and I.B. Salusky. 1994. Development of a dynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Intl. 46: 1160-1166.
48. Grigoriadis, A.E., K. Schellander, Z.Q. Wang, and E.F. Wagner. 1993. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell. Biol. 122: 685-701.
49. Grigoriadis, A.E., Z.Q. Wang, M.G. Cecchini, W. Hofstetter, R. Felix, H.A. Fleisch, and E.F. Wagner. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448.
50. Grigoriadis, A.E., Z.Q. Wang, and E.F. Wagner. 1995. Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet. 11: 436-441.
51. Hall, B.K. and T. Miyake. 1992. The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. Anat. Embryol. 186: 107-124.
52. Hauschka, P.V., J.B. Lian, D.E.C. Cole, and C.M. Gundberg. 1989. Osteocalcin and matrix gla protein: Vitamin K-dependent proteins in bone. In Physiol. Rev.69: 990-1046.
53. Hayman, A.R., S.J. Jones, A. Boyde, D. Foster, W.H. Colledge, M.B. Carlton, M.J. Evans, and T.M. Cox. 1996. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122: 3151-3162.
54. Hertwig, P. 1942. Neue mutationen und kopplungsgruppen bei der hausmaus. Z. Indukt. Abstammungs-Vererbungsl. 80: 220-246.
55. Hodgkinson, C.A., K.J. Moore, A. Nakayama, E. Steingrímsson, N.G. Copeland, N.A. Jenkins, and H. Arnheiter. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74: 395-404.
56. Hofstetter, W., A. Wetterwald, M.G. Cecchini, C. Mueller, and R. Felix. 1995. Detection of transcripts and binding sites for colony-stimulating factor-1 during bone development. Bone 17: 145-151.
57. Hogan, B.L.M. 1996. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes & Dev. 10: 1580-1594.
58. Horton, W.A. 1993. Morphology of connective tissue: Cartilage. In Connective tissue and its heritable disorders, pp. 73-84. Wiley-Liss, New York, NY.
59. Horwood, N.J., V. Kartsogiannis, M.H.X. Lam, E. Romas, J.M.W. Quinn, T.J. Martin, and M.T. Gillespie. 1998. Activated T cells are capable of inducing osteoclast formation: A mechanism for rheumatoid arthritis. In Second Joint Meting of The American Society for Bone and Mineral Research and The International Bone and Mineral Society (ed. M.C. Drezner), pp. S214. Elsevier Science, Inc., San Francisco, CA.
60. Hou, W.S., D. Bromme, Y. Zhao, E. Mehler, C. Dushey, H. Weinstein, C.S. Miranda, C. Fraga, F. Greig, J. Carey, D.L. Rimoin, R.J. Desnick, and B.D. Gelb. 1999. Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J. Clin. Invest. 103: 731-738.
61. Hsu, H., D.L. Lacey, C.R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H.L. Tan, G. Elliott, M.J. Kelley, I. Sarosi, L. Wang, X.Z. Xia, R. Elliott, L. Chiu, T. Black, S. Scully, C. Capparelli, S. Morony, G. Shimamoto, M.B. Bass, and W.J. Boyle. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. 96: 3540-3545.
62. Huang, L.F., N. Fukai, P.B. Selby, B.R. Olsen, and S. Mundlos. 1997. Mouse clavicular development: analysis of wild-type and cleidocranial dysplasia mutant mice. Dev. Dyn. 210: 33-40.
63. Hunter, G.K., P.V. Hauschka, A.R. Poole, L.C. Rosenberg, and H.A. Goldberg. 1996. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J. 317: 59-64.
64. Hurley, D.L., R.D. Tiegs, H.W. Wahner, and H.D. Heath. 1987. Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. New Engl. J. Med. 317: 537-541.
65. Inada, M., T. Yasui, S. Nomura, S. Miyake, K. Deguchi, M. Himeno, M. Sato, H. Yamagiwa, T. Kimura, N. Yasui et al. 1999. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 214: 279-290.
66. Iotsova, V., J. Caamaño, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3: 1285-1289.
67. Ji, C., S. Casinghino, D.J. Chang, Y. Chen, A. Javed, Y. Ito, S.W. Hiebert, J.B. Lian, G.S. Stein, T.L. McCrthy, and M. Centrella. 1998. CBFa1 (AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J. Cell. Biochem. 69: 353-363.
68. Jimenez, M.J., M. Balbin, J.M. Lopez, J. Alvarez, T. Komori, and C. Lopez-Otin. 1999. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol. Cell. Biol. 19: 4431-4442.
69. Jobert, A.S., P. Zhang, A. Couvineau, J. Bonaventure, J. Roume, M. Le Merrer, and C. Silve. 1998. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J. Clin. Invest. 102: 34-40.
70. Johnson, R.S., B.M. Spiegelman, and V. Papaioannou. 1992. Pleitropic effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577-586.
71. Jones, S.M. and A.K. Bhalla. 1993. Osteoporosis in rheumatoid arthritis. Clin. Exp. Rheumatol. 11: 557-562.
72. Jüppner, H., A.B. Abou-Samra, M. Freeman, X.F. Kong, E. Schipani, J. Richards, L.F.J. Kolakowski, J. Hock, J.T.J. Potts, H.M. Kronenberg et al. 1991. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254: 1024-1026.
73. Karaplis, A.C., A. Luz, J. Glowacki, R.T. Bronson, V.L. Tybulewicz, H.M. Kronenberg, and R.C. Mulligan. 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes & Dev. 8: 277-289.
74. Karsenty, G. 1998. Genetics of skeletogenesis. Dev. Gen. 22: 301-313.
75. Kawasaki, K., Y.H. Gao, S. Yokose, Y. Kaji, T. Nakamura, T. Suda, K. Yoshida, T. Taga, T. Kishimoto, H. Kataoka, T. Yuasa, H. Norimatsu, and A. Yamaguchi. 1997. Osteoclasts are present in gp130-deficient mice. Endocrinology 138: 4959-4965.
76. Kessler, E., K. Takahara, L. Biniaminov, M. Brusel, and D.S. Greenspan. 1996. Bone morphogenetic protein-1: The type I procollagen C-proteinase. Science 271: 360-362.
77. Khillan, J.S., A.S. Olsen, S. Kontusaari, B. Sokolov, and D.J. Prockop. 1991. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J. Biol. Chem. 255: 23373-23379.
78. Kim, I.S., F. Otto, B. Abel, and S. Munmdlos. 1999. Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 80: 159-170.
79. Klemsz, M.J., S.R. McKercher, A. Celada, C. Van Beveren, and R.A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61: 113-124.
80. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
81. Kong, Y.Y., H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, C. Capparelli, S. Morony, A.J. Oliveira-dos-Santos, G. Van, A. Itie et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
82. Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
83. Lagasse, E. and I.L. Weissman. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89: 1021-1031.
84. Lanske, B., M. Amling, L. Neff, J. Guiducci, R. Baron, and H.M. Kronenberg. 1999. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J. Clin. Invest. 104: 399-407.
85. Lee, B., K. Thirunavukkarasu, L. Zhou, L. Pastore, A. Baldini, J. Hecht, V. Geoffroy, P. Ducy and G. Karsenty. 1997a. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/Cbfa1 in cleidocranial dysplasia. Nat. Genet. 16: 307-310.
86. Lee, S., D.E. Solow-Cordero, E. Kessler, K. Takahara, and D.S. Greenspan. 1997b. Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J. Biol. Chem. 272: 19056-19066.
87. Levanon, D., V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23: 425-432.
88. Li, Y.C., A.E. Pirro, M. Amling, G. Delling, R. Baron, R. Bronson, and M.B. Demay. 1997. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. 94: 9831-9835.
89. Li, Y.C., M. Amling, A.E. Pirro, M. Priemel, J. Meuse, R. Baron, G. Delling, and M.B. Demay. 1998. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139: 4391-4396.
90. Liaw, E. Birk, C.B. Ballas, J.S. Whitsitt, J.M. Davidson, and B.L. Hogan. 1998. Altered wound healing in mice lacking a functional osteopontin gene (sppl). J. Clin. Invest. 101: 1468-1478.
91. Liu, X., H. Wu, M. Byrne, J. Jeffrey, S. Krane, and R. Jaenisch. 1995. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell. Biol. 130: 227-237.
92. Lomaga, M.A., W.C. Yeh, I. Sarosi, G.S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes & Dev. 13: 1015-1024.
93. Lowe, C., T. Yoneda, B.F. Boyce, H. Chen, G. Mundy, and P. Soriano. 1993. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. 15: 4485-4489.
94. Lowell, C.A. and P. Soriano. 1996. Knockouts of Src-family kinases: Stiff bones, wimpy T cells, and bad memories. Genes & Dev. 10: 1845-1857.
95. Luo, G., P. Ducy, M.D. McKee, G.J. Pinero, E. Loyer, R.R. Behringer, and G. Karsenty. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81.
96. Manolagas, S.C., R.L. Jilka, T. Bellido, C.A. O'Brien, and A.M. Parfitt. 1996. Interleukin-6-type cytokines and their receptors. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan), pp. 701-713. Academic Press, San Diego, CA.
97. Marini, J.C., S. Bordenick, G. Heavner, S. Rose, R. Hintz, R. Rosenfeld, and G.P. Chrousos. 1993. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. J. Clin. Endocrinol. Metab. 76: 251-256.
98. Marks, S.C.J. and P.W. Lane. 1976. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 67: 11-18.
99. Marks, S.C.J., M.F. Seifert, and J.L. McGuire. 1984. Congenitally osteopetrotic (op/op) mice are not cured by transplants of spleen or bone marrow cells from normal littermates. Metab. Bone Dis. Relat. Res. 5: 183-186.
100. McKercher, S.R., B.E. Torbett, K.L. Anderson, G.W. Henkel, D.J. Vestal, H. Baribault, M. Klemsz, A.J. Feeney, G.E. Wu, C.J. Paige, and R.A. Maki. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647-5658.
101. Mizuno, A., N. Amizuka, K. Irie, A. Murakami, N. Fujise, T. Kanno, Y. Sato, N. Nakagawa, H. Yasuda, S. Mochizuki et al. 1998. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Comm. 247: 610-615.
102. Mundlos, S., F. Otto, C. Mundlos, J.B. Mulliken, A.S. Aylsworth, S. Albright, D. Lindhout, W.G. Cole, W. Henn, J.H. Knoll et al. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779.
103. Mundy, G.R., B.F. Boyce, T. Yoneda, L.F. Bonewald, and G.D. Roodman. 1996. Cytokines and bone remodeling (ed. R. Marcus, D. Feldman, J. Kelsey). pp. Academic Press, San Diego, CA.
104. Narisawa, S., N. Fröhlander, and J.L. Millán. 1997. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev. Dyn. 208: 432-446.
105. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. 90: 6859-6863.
106. Oldberg, A., A. Franzén, and D. Heinegård. 1986. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. 83: 8819-8823.
107. Oreffo, R.O., V. Kusec, A.S. Virdi, A.M. Flanagan, M. Grano, A. Zambonin-Zallone, and J.T. Triffitt. 1999. Expression of estrogen receptor-alpha in cells of the osteoclastic lineage. Histochem. Cell. Biol. 111: 125-133.
108. Otto, F., A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, I.R. Rosewell, G.W. Stamp, R.S. Beddington, S. Mundlos, B.R. Olsen, P.B. Selby, and M.J. Owen. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
109. Oursler, M.J., P. Osdoby, J. Pyfferoen, B.L. Riggs, and T.C. Spelsberg. 1991. Avian osteoclasts as estrogen target cells. Proc. Natl. Acad. Sci. 88: 6613-6617.
110. Owens, J.M., K. Matsuo, G.C. Nicholson, E.F. Wagner, and T.J. Chambers. 1999. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines. J. Cell. Physiol. 179: 170-178.
111. Pacifici, R. 1998. Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. Endocrinology 139: 2659-2661.
112. Piepkorn, B., P. Kann, T. Forst, J. Andreas, A. Pfützner, and J. Beyer. 1997. Bone mineral density and bone metabolism in diabetes mellitus. Hormone Metab. Res. 29: 584-591.
113. Porte, D., J. Tuckermann, M. Becker, B. Baumann, S. Teurich, T. Higgins, M.J. Owen, M. Schorpp-Kistner, and P. Angel. 1999. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 18: 667-678.
114. Prockop, D.J., H. Kuivaniemi, and G. Tromp. 1994. Molecular basis of osteogenesis imperfecta and related disorders of bone. Clin. Plastic Surg. 21: 407-413.
115. Rifas, L., L.S. Holliday, S.L. Gluck, and L.V. Aviolo. 1998. Activated T cells induce osteoclastogenesis. In Second Meeting of the The American Society for Bone and Mineral Research and The International Bone and Mineral Society (ed. M.C. Drezner), pp. S195. Elsevier Science, Inc., San Francisco, CA.
116. Rittling, S.R., H.N. Matsumoto, M.D. McKee, A. Nanci, X.R. An, K.E. Novick, A.J. Kowalski, M. Noda, and D.T. Denhardt. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Min. Res. 13: 1101-1111.
117. Rodan, G., L.G. Raisz, and J.P. Bilezikian. 1996. Pathophysiology of osteoporosis. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, G. Rodan), pp. 979-990. Academic Press, San Diego, CA.
118. Rossert, J., H. Eberspaecher and B. De Crombrugghe. 1996. Separate cis-acting DNA elements of the mouse pro-alpha1 (i) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J. Cell. Biol. 129: 1421-1432.
119. Saftig, P., E. Hunziker, O. Wehmeyer, S. Jones, A. Boyde, W. Rommerskirch, J.D. Moritz, P. Schu, and K. von Figura. 1998. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. 95: 13453-13458.
120. Schinke, T. and G. Karsenty. 1999. Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse osteocalcin promoter. J. Biol. Chem. 274: 30182-30189.
121. -/- mutant mice. Genes & Dev. 11: 2835-2844.
122. Scott, E.W., M.C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577.
123. Seligman, M., R.F. Eilberg, and L. Fishman. 1975. Mineralization of elastin extracted from human aortic tissues. Calcif. Tissue Res. 17: 229-234.
124. Sherr, C.J., C.W. Rettenmier, R. Sacca, M.F. Roussel, A.T. Look, and E.R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41: 665-676.
125. Shimell, M.J., E.L. Ferguson, S.R. Childs, and M.B. O'Connor. 1991. The Drosophila dorsal-ventral patterning gene tolloid is related to human bone morphogenetic protein 1. Cell 67: 469-481.
126. Sillence, D.O., H.E. Ritchie, and P.B. Selby. 1987. Animal model: Skeletal anomalies in mice with cleidocranial dysplasia. Am. J. Med. Genet. 27: 75-85.
127. Simonet, W.S., D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Lüthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone et al. 1997. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
128. Slatopolsky, E. and J.A. Delmez. 1998. Renal Osteodystrophy. In Metabolic bone disease and clinically related disorders (ed. L.F. Aviolo and S.M. Krane), pp. 443-463. Academic Press, San Diego, CA.
129. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
130. Speck, N.A. and T. Stacy. 1995. A new transcription factor family associated with human leukemias. CRC Crit. Rev. Eukaryot. Gene Expression 5: 337-364.
131. St-Jacques, B., M. Hammerschmidt, and A.P. McMahon. 1999. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes & Dev. 13: 2072-2086.
132. Suda, T., N. Udagawa, and N. Takahashi. 1996. Cells of bone: osteoclast generation. In Principles of bone biology (ed. J.P. Bilezikian, L.G. Raisz, G.A. Rodan), pp. 87-102. Academic Press, San Diego, CA.
133. Suzuki, N., P.A. Labosky, Y. Furuta, L. Hargett, R. Dunn, A.B. Fogo, K. Takaharar, D.M. Peters, D.S. Greenspan, and B.L. Hogan. 1996. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development 122: 3587-3595.
134. Tanaka, S., M. Amling, L. Neff, A. Peyman, E. Uhlmann, J.B. Levy, and R. Baron. 1996. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 383: 528-531.
135. Teitelbaum, S.L., M.M. Tondravi, and F.P. Ross. 1996. Osteoclast biology. In Osteoporosis (ed. R. Marcus, D. Feldman, J. Kelsey), pp. 61-94. Academic Press, San Diego, CA.
136. Tondravi, M.M., S.R. McKercher, K. Anderson, J.M. Erdmann, M. Quiroz, R. Maki, and S.L. Teitelbaum. 1997. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386: 81-84.
137. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes & Dev. 9: 2723-2735.
138. Vortkamp, A., K. Lee, B. Lanske, G.V. Segre, H.M. Kronenberg, and C.J. Tabin. 1996. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273: 613-622.
139. Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D Shapiro, R.M. Senior, and Z. Werb. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422.
140. Wang, Z.Q., C. Ovitt, A.E. Grigoriadis, U. Möhle-Steinlein, U. Rüther, and E.F. Wagner. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature 360: 741-745.
141. Ward, J.M. and D.M. Young. 1976. Histogenesis and morphology of periosteal sarcomas induced by FBJ virus in NIH Swiss mice. Cancer Res. 36: 3985-3992.
142. Warshawsky, H. 1982. Embryology and development of the skeletal system. In The Musculoskeletal System: Embryology, biochemistry and physiology, pp. 33-56. Churchill Livingston Press, New York, NY.
143. Waymire, K.G., J.D. Mahuren, J.M. Jaje, T.R. Guilarte, S.P. Coburn, and G.R. MacGregor. 1995. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat. Genet. 11: 45-51.
144. Whyte, M.P. 1994. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocrin. Rev. 15: 439-461.
145. Wimalawansa, S.J. 1997. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: A peptide superfamily. CRC Crit. Rev. Neurobiol. 11: 167-239.
146. Wong, B.R., R. Josien, S.Y. Lee, M. Vologodskaia, R.M. Steinman, and Y. Choi. 1998. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J. Biol. Chem. 273: 28355-28359.
147. Xu, T., P. Bianco, L.W. Fisher, G. Longenecker, E. Smith, S. Goldstein, J. Bonadio, A. Boskey, A.M. Heegaard, B. Sommer et al. 1998. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 20: 78-82.
148. Yasuda, H., N. Shima, N. Nakagawa, S.I. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama et al. 1998. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 1329-1337.
149. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L.D. Schulz, and S. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.
150. Yoshizawa, T., Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Y. Yoshihara, T. Kawakami, K. Arioka, H. Sato, Y. Uchiyama et al. 1997. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16: 391-396.
151. Zhao, W., M.H. Byrne, B.F. Boyce, and S.M. Krane. 1999. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J. Clin. Invest. 103: 517-524.